Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Debt to Equity (2020 - 2025)

Eton Pharmaceuticals' Debt to Equity history spans 6 years, with the latest figure at $1.17 for Q4 2025.

  • On a quarterly basis, Debt to Equity fell 4.26% to $1.17 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.17, a 4.26% decrease, with the full-year FY2025 number at $1.17, down 4.26% from a year prior.
  • Debt to Equity hit $1.17 in Q4 2025 for Eton Pharmaceuticals, down from $1.31 in the prior quarter.
  • Over the last five years, Debt to Equity for ETON hit a ceiling of $1.31 in Q3 2025 and a floor of $0.02 in Q1 2021.
  • Historically, Debt to Equity has averaged $0.38 across 5 years, with a median of $0.11 in 2023.
  • Biggest five-year swings in Debt to Equity: decreased 23.9% in 2022 and later soared 408.72% in 2025.
  • Tracing ETON's Debt to Equity over 5 years: stood at $0.08 in 2021, then fell by 1.79% to $0.08 in 2022, then surged by 340.08% to $0.35 in 2023, then skyrocketed by 251.07% to $1.22 in 2024, then fell by 4.26% to $1.17 in 2025.
  • Business Quant data shows Debt to Equity for ETON at $1.17 in Q4 2025, $1.31 in Q3 2025, and $1.26 in Q2 2025.